EyePoint Pharmaceuticals
EYPT
#6026
Rank
โ‚ฌ0.90 B
Marketcap
10,75ย โ‚ฌ
Share price
5.75%
Change (1 day)
96.11%
Change (1 year)

Revenue for EyePoint Pharmaceuticals (EYPT)

Revenue in 2025 (TTM): โ‚ฌ28.47 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ26.97 Million. a decrease over the revenue in the year 2024 that were of โ‚ฌ41.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for EyePoint Pharmaceuticals from 2003 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ26.7 M-35.78%
2024 โ‚ฌ41.58 M-0.11%
2023 โ‚ฌ41.62 M7.85%
2022 โ‚ฌ38.59 M18.34%
2021 โ‚ฌ32.61 M16.5%
2020 โ‚ฌ27.99 M54.02%
2019 โ‚ฌ18.17 M
2017 โ‚ฌ2.17 M-66.74%
2016 โ‚ฌ6.53 M313.39%
2015 โ‚ฌ1.58 M-93.16%
2014 โ‚ฌ23.11 M1354.94%
2013 โ‚ฌ1.58 M-11.52%
2012 โ‚ฌ1.79 M-63.36%
2011 โ‚ฌ4.9 M-61.94%
2010 โ‚ฌ12.87 M39.74%
2009 โ‚ฌ9.21 M42.8%
2008 โ‚ฌ6.45 M1154.57%
2007 โ‚ฌ0.51 M-67.06%
2006 โ‚ฌ1.56 M36.53%
2005 โ‚ฌ1.14 M259.02%
2004 โ‚ฌ0.31 M125.82%
2003 โ‚ฌ0.14 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
โ‚ฌ0.11 B 343.40%๐Ÿ‡บ๐Ÿ‡ธ USA